PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
19.06%
Some net income increase while MCHP is negative at -89.37%. John Neff would see a short-term edge over the struggling competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
503.40%
Lower 'other non-cash' growth vs. MCHP's 5377.31%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
83.58%
Operating cash flow growth above 1.5x MCHP's 55.49%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-48.00%
Both yoy lines negative, with MCHP at -80.34%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
100.00%
Acquisition growth of 100.00% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-9.43%
Negative yoy purchasing while MCHP stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
37.98%
Liquidation growth of 37.98% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
No Data
No Data available this quarter, please select a different quarter.
2.45%
We have mild expansions while MCHP is negative at -80.34%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
933.33%
Stock issuance far above MCHP's 1748.92%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
41.67%
Repurchase growth above 1.5x MCHP's 25.96%. David Dodd would see a strong per-share advantage if the share price is reasonably valued.